Cooper Companies Reports Q3 Earnings and Fertility Growth Amid CooperVision Weakness
The Cooper Companies Inc. (NASDAQ:COO) reported third-quarter fiscal year 2026 results, showing a 1% increase in revenue to $1.066 billion compared to the same period last year. Adjusted diluted earnings per share rose by 4%, reaching $1.15. The company spent $339.1 million on repurchasing approximately 4.9 million shares and has remaining buyback capacity of $1.5 billion after a recent authorization increase. Strong performance in the fertility segment, particularly within CooperSurgical, offset weaker results from CooperVision. Free cash flow surged by 66% to $273.0 million due to strong operating cash flows. However, CooperVision experienced flat organic growth and revenue declines in key regions like Asia Pacific and Americas. Despite these challenges, the company maintained a positive outlook with strategic priorities focused on profitable expansion and long-term free cash flow targets exceeding $2.2 billion by FY28.
Tickers: $COO